Warfarin therapy
56 results
1 - 56
Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter: Cochrane systematic review- Warfarin initiation nomograms for venous thromboembolism: Cochrane systematic review
- Antiplatelet versus anticoagulation treatment for people with heart failure in sinus rhythm
- Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks: Cochrane systematic review
- Optimal loading dose of warfarin for the initiation of oral anticoagulation
- Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
- Non‐vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta‐analysis
- Vitamin K for improved anticoagulation control in patients receiving warfarin: Cochrane systematic review
- Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks: Cochrane systematic review
- Anticoagulation versus placebo for heart failure in sinus rhythm
- Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non‐valvular atrial fibrillation
- Oral anticoagulants for preventing stroke in patients with non‐valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
- Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
- Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack: Cochrane systematic review
- Antiplatelet agents and anticoagulants for hypertension
- Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy: Cochrane systematic review
- Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts
- Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation
- Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack: Cochrane systematic review
- Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
- Anticoagulation therapy versus placebo for pulmonary hypertension
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
- Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty: Cochrane systematic review
- Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin: Cochrane systematic review
- Pentasaccharides for the treatment of deep vein thrombosis
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Interventions for preventing thrombosis in solid organ transplant recipients
- Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
- Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions
- Antiplatelet and anticoagulation for patients with prosthetic heart valves
- Non-steroid agents for idiopathic pulmonary fibrosis: Cochrane systematic review
- Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease: Cochrane systematic review